Presentations:
|
Overview
of
the
Israeli
start
up
pharmaceutical
industry
|
Nissim
Darvish
M.D.,
Ph.D.
Senior
Managing
Director,
OrbiMed
Israel
|
|
|
Quality
and
Regulatory
aspects
in
early
phase
development
of
pharmaceutical
products
|
Rivka
Zaibel
Founder,
CEO
and
Consultant
ADRES,
Advanced
Regulatory
Services
Ltd.
|
|
|
The
Israeli
Healthtech
Industry
in
the
Era
of
Precision
Medicine
|
Itai
Kela,
PhD,
MBA
Senior
Director,
Healthcare
&
Biotechnology
Sector
Technology
Division
Israel
Innovation
Authority
|
|
|
Strategic
Considerations
for
Manufacturing
Process
Development
|
Oren
Hershkovitz,
Ph.D.
General
Manager
OPKO
Biologics
Ltd.
(f.k.a.
Prolor-Biotech
Ltd.)
|
|
|
Preclinical
and
Toxicological
aspects
in
early
phase
development
of
pharmaceutical
products
|
Liat
Hershkovitz,
Ph.D
Director,
Scientific
and
Regulatory
Affairs
ADRES
Advanced
Regulatory
Services
Ltd.
|
|
|
Developing
your
Process
for
future
scale-up
and
commercial
viability
|
Sarel
Chen-Tov
CEO,
Biopharmax
Ltd
|
|
|
Drug
Development
-
Points
to
Consider
The
Regulator
View
|
Dr.
Ofra
Axelrod
Director
of
The
Institute
for
Standardization
and
Control
of
Pharmaceuticals,
Israeli
MOH
|
